Inventor · disambiguated record
Ivan David Horak
Also filed as: HORAK IVAN · HORAK IVAN D · HORAK IVAN DAVID
7 granted patents·21 pending applications·55 citations·filing 2001–2024
82Inventor score
Files withSYMPHOGEN AS6ENZON PHARMACEUTICALS INC3IMMUNOMEDICS INC3CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2PALMER PETER ALBERT2
Top patents by PatentIndex Score
28 records- 0194US7531327B2Methods and compositions for increasing longevity and protein yield from a cell cultureIMMUNOMEDICS INC·Filed 2005·Granted May 12, 2009·30 cites·17 claims
- 0293US11034765B2Anti-PD-1 antibodies and compositionsSYMPHOGEN AS·Filed 2016·Granted Jun 15, 2021·17 cites·20 claims
- 0386US11390676B2Anti-LAG-3 antibodies and compositionsSYMPHOGEN AS·Filed 2017·Granted Jul 19, 2022·3 cites·15 claims
- 0485US11390674B2Anti-TIM-3 antibodies and compositionsSYMPHOGEN AS·Filed 2017·Granted Jul 19, 2022·4 cites·23 claims
- 0575US2024052032A1Anti-lag-3 antibodies and compositionsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2023·Application pending·0 cites
- 0673US11834503B2Anti-lag-3 antibodies and compositionsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Granted Dec 5, 2023·0 cites·20 claims
- 0773US2024270848A1Combination therapies targeting pd-1, tim-3, and lag-3SERVIER LAB·Filed 2024·Application pending·0 cites
- 0871US11939380B2Combination therapies targeting PD-1, TIM-3, and LAG-3SYMPHOGEN AS·Filed 2018·Granted Mar 26, 2024·1 cites·16 claims
- 0969US2009018164A1Farnesyl protein transferase inhibitors for treating breast cancerPALMER PETER ALBERT·Filed 2008·Application pending·0 cites
- 1067US2022380470A1Combination therapies targeting pd-1, tim-3, and lag-3SYMPHOGEN AS·Filed 2022·Application pending·0 cites
- 1160US2004192726A1Farnesyl protein transferase inhibitors for treating breast cancerFiled 2004·Application pending·0 cites
- 1255US12030942B2Anti-PD-1 antibodies and compositionsSERVIER LAB·Filed 2021·Granted Jul 9, 2024·0 cites·18 claims
- 1351US2003027839A1Farnesyl protein transferase inhiitors for treating breast cancerFiled 2001·Application pending·0 cites
- 1451US2010056555A1Method of treating ras associated cancerENZON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1550US2023263890A1Treatment of cd30-positive cancerTESSA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1649US2011098318A1Farnesyl protein transferase inhibitors for treating breast cancerPALMER PETER ALBERT·Filed 2011·Application pending·0 cites
- 1747US2009202573A1Polymeric conjugates containing positively-charged moietiesENZON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1847US2008159964A1Use of adenosine deaminase for treating pulmonary diseaseENZON PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1946US2005079184A1Bispecific antibodies for inducing apoptosis of tumor and diseased cellsIMMUNOMEDICS INC·Filed 2004·Application pending·0 cites
- 2045US2007092947A1Methods and compositions for increasing longevity and protein yield from a cell cultureIMMUNOMEDICS INC·Filed 2005·Application pending·0 cites
- 2141US2020347140A1Compositions and methods for treating cancer with anti-egfr antibodiesSYMPHOGEN AS·Filed 2018·Application pending·0 cites
- 2241US2003181473A1Farnesyl protein transferase inhibitor combinations with taxane compoundsFiled 2001·Application pending·0 cites
- 2341US2003186925A1Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivativesFiled 2001·Application pending·0 cites
- 2436US2003022918A1Farnesyl protein transferase inhibitor combinations with an her2 antibodyFiled 2001·Application pending·0 cites
- 2536US2003060480A1Farnesyl protein transferase inhibitor combinations with vinca alkaloidsFiled 2001·Application pending·0 cites
- 2634US2003212008A1Farnesyl protein transferase inhibitor combinations with further anti-cancer agentsFiled 2001·Application pending·0 cites
- 2734US2003027808A1Farnesyl protein transferase inhibitor combinations with platinum compoundsFiled 2001·Application pending·0 cites
- 2834US2003100553A1Farnesyl protein transferase inhibitor combinations with camptothecin compoundsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →